Quetiapine-induced extrapyramidal side effects in patients with Parkinson's disease: Case report

Journal of Geriatric Psychiatry and Neurology

Volumn 14, Issue 2, 2001, Pages 99-100

  Sommer, B R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CLOZAPINE; DIGOXIN; DIPHENHYDRAMINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; POTASSIUM; PROPRANOLOL; QUETIAPINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG CHOICE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0034975074     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198870101400210     Document Type: Article

References (8)

1. Parkinson's disease: One illness or many syndromes?
2. Auditory hallucinations in Parkinson's disease
3. Receptor pharmacology of neuroleptics: Relation to clinical effects
4. Efficacy of quetiapine in Parkinson's patients with psychosis
5. Quetiapine (seroquel) in the treatment of psychosis in patients with Parkinson's disease
6. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo
7. 'Seroquel' (quetiapine): Preclinical and clinical findings of a new atypical antipsychotic
8. Quetiapine for elderly patients with psychotic disorders